22
Participants
Start Date
August 26, 2021
Primary Completion Date
June 29, 2022
Study Completion Date
June 29, 2022
Bionic Pancreas
Bionic pancreas system: The bionic pancreas is an autonomous, self-learning system that requires only the subject's weight for initialization, and then autonomously adapts insulin dosing to maintain glycemic control. The bionic pancreas uses continuous glucose monitoring as input to the controller. The bionic pancreas can be used in a bi-hormonal configuration, administering both insulin and glucagon as well as an insulin only setting.
Usual Care
Subjects will remain on home insulin regimen (either insulin pump or injectable insulin). Subjects in usual care will wear a study CGM even if in typical care does not include CGM use.
Massachusetts General Hospital, Boston
Collaborators (1)
Beta Bionics, Inc.
INDUSTRY
Massachusetts General Hospital
OTHER